{"id":"https://openalex.org/W7204701491","doi":"https://doi.org/10.1016/s2152-2650(26)01005-0","title":"POSTER: MPN-1689: Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis","display_name":"POSTER: MPN-1689: Impact of GLP-1 Agonists on Clinical Outcomes in Patients With Essential Thrombocythemia: A Propensity-Matched Analysis","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204701491","doi":"https://doi.org/10.1016/s2152-2650(26)01005-0"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01005-0","doi":"https://doi.org/10.1016/s2152-2650(26)01005-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01005-0","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204701491"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092817833","display_name":"Nneoma Ubah","orcid":"https://orcid.org/0009-0007-4229-0455","observed_orcids":["https://orcid.org/0009-0007-4229-0455"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nneoma Ubah","raw_affiliation_strings":["Montefiore St Luke Cornwall Hospital, Newburgh, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montefiore St Luke Cornwall Hospital, Newburgh, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115009816","display_name":"Chidiebube J. Ugwu","orcid":"https://orcid.org/0000-0002-7696-6800","observed_orcids":["https://orcid.org/0000-0002-7696-6800"]},"institutions":[{"id":"https://openalex.org/I2801887358","display_name":"Jefferson Einstein Philadelphia Hospital","ror":"https://ror.org/03vzpaf33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801887358","https://openalex.org/I4210111876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chidiebube Ugwu","raw_affiliation_strings":["Jefferson Einstein Hospital, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jefferson Einstein Hospital, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I2801887358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148672510","display_name":"Nnamdi Joseph Omenuko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119443389","display_name":"East Tennessee State University","ror":"https://ror.org/05rfqv493","country_code":"US","type":"education","lineage":["https://openalex.org/I119443389"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nnamdi Omenuko","raw_affiliation_strings":["East Tennessee State University, Johnson City, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"East Tennessee State University, Johnson City, TN, USA","institution_ids":["https://openalex.org/I119443389"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S292","last_page":"S292"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9369999766349792},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.7929999828338623},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9089999794960022},{"id":"https://openalex.org/keywords/thrombotic-risk","display_name":"thrombosis risk","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9742000102996826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46950000524520874},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4260999858379364},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.32199999690055847},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3084000051021576},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2881999909877777},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.23250000178813934},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18459999561309814},{"id":"https://openalex.org/C2780454255","wikidata":"https://www.wikidata.org/wiki/Q7111916","display_name":"Outcomes research","level":3,"score":0.18029999732971191},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.17949999868869781}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01005-0","doi":"https://doi.org/10.1016/s2152-2650(26)01005-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01005-0","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413781333","https://openalex.org/W7204682514","https://openalex.org/W7204701452","https://openalex.org/W7204716972","https://openalex.org/W7204690056","https://openalex.org/W4413810229","https://openalex.org/W7204717319","https://openalex.org/W4413791295","https://openalex.org/W4413791317","https://openalex.org/W7204709174"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204701491","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}
